Bruker logo

Bruker

North America, Massachusetts, United States, Billerica

Description

Bruker is a manufacturer of analytical and medical instruments covering NMR, ESR, FT-IR, X-RAY spectroscopy.

Investor Profile

Bruker has made 12 investments, with 3 in the past 12 months and 33% as lead.

Stage Focus

  • Series A (25%)
  • Series Unknown (25%)
  • Seed (17%)
  • Series B (8%)
  • Series C (8%)
  • Corporate Round (8%)
  • Series D (8%)

Country Focus

  • United States (75%)
  • Switzerland (8%)
  • France (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Health Diagnostics
  • Life Science
  • Biopharma
  • Therapeutics
  • Genetics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bruker frequently co-invest with?

LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 2
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 3
Wing Venture Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Emerson Collective
North America, California, United States, Palo Alto
Co-Investments: 2
aMoon Fund
Asia, HaMerkaz, Israel, Ra'anana
Co-Investments: 3
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 2
Maverick Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Invus
North America, New York, United States, New York
Co-Investments: 3
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 2

Which angels does Bruker often collaborate with?

JE
North America, New York, United States, New York
Shared Deals: 1
JM
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Bruker?

Terrain BioSciences accelerates RNA-based therapeutics and vaccine development using AI and proprietary platforms.

Biotechnology
SeedFeb 12, 2025
Amount Raised: $9,000,000
PrognomiQ

San Mateo, California, United States

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

BiopharmaBiotechnologyHealth CareMedical Device
Series DNov 5, 2024
Amount Raised: $34,000,000
NovAliX

Illkirch, Alsace, France

NovAliX is a company that aids managers, scientists, and project managers with drug discovery projects.

Biotechnology
Corporate RoundAug 7, 2024
Tome Biosciences

Watertown, Massachusetts, United States

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.

BiotechnologyGeneticsMedical
Series ADec 12, 2023
Amount Raised: $213,000,000
Mercy BioAnalytics

Natick, Massachusetts, United States

Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.

BiotechnologyHealth CareLife ScienceTherapeutics
Series AApr 3, 2023
Amount Raised: $41,000,000
KIYATEC

Greenville, South Carolina, United States

KIYATEC utilizes the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies.

BiotechnologyHealth DiagnosticsLife Science
Series CDec 12, 2022
Amount Raised: $18,000,000
Haystack Oncology

Baltimore, Maryland, United States

Haystack Oncology enables precision oncology to optimize treatment strategies.

BiotechnologyHealth DiagnosticsMedicalOncology
Series ANov 16, 2022
Amount Raised: $56,000,000
Navignostics

Zürich, Zurich, Switzerland

Navignostics aims to identify the ideal treatment to each cancer patient’s disease.

BioinformaticsBiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalMedical DevicePersonal Health
SeedNov 9, 2022
Amount Raised: $7,624,780
PrognomiQ

San Mateo, California, United States

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

BiopharmaBiotechnologyHealth CareMedical Device
Series UnknownMar 15, 2022
Amount Raised: $46,000,000
Ionpath

Menlo Park, California, United States

Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series BSep 24, 2020
Amount Raised: $18,000,000